ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) was the recipient of a large decrease in short interest in the month of June. As of June 30th, there was short interest totaling 14,273 shares, a decrease of 39.3% from the June 15th total of 23,522 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily volume of 69,188 shares, the days-to-cover ratio is currently 0.2 days.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a research report on Monday, July 6th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.
View Our Latest Analysis on ALPS
ALPS Group Inc Ordinary Share Stock Up 1.6%
About ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
Featured Stories
- Five stocks we like better than ALPS Group Inc Ordinary Share
- 3 Picks-and-Shovels Stocks Powering the Humanoid Robotics Buildout
- J.B. Hunt Stock Could Reach $340 as Trucking Capacity Shrinks
- The AI Data Center Boom Is Bigger Than One Stock—These ETFs Spread the Bet
- Palantir’s Wild Ride: Inside the Stock Wall Street Can’t Agree On
Receive News & Ratings for ALPS Group Inc Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Group Inc Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.
